Found 29 results
Author Title Type [ Year(Asc)]
Filters: Keyword is Tuberculosis and Author is Luiz E Bermudez  [Clear All Filters]
2016
L. Danelishvili, Everman, J., and Bermudez, L. E., “Mycobacterium tuberculosis PPE68 and Rv2626c genes contribute to the host cell necrosis and bacterial escape from macrophages.”, Virulence, vol. 7, no. 1, pp. 23-32, 2016.
2015
L. E. Bermudez, Danelishvili, L., Babrack, L., and Pham, T., “Evidence for genes associated with the ability of Mycobacterium avium subsp. hominissuis to escape apoptotic macrophages.”, Front Cell Infect Microbiol, vol. 5, p. 63, 2015.
2014
L. Danelishvili, Stang, B., and Bermudez, L. E., “Identification of Mycobacterium avium genes expressed during in vivo infection and the role of the oligopeptide transporter OppA in virulence.”, Microb Pathog, vol. 76, pp. 67-76, 2014.
2010
Y. -jun Li, Danelishvili, L., Wagner, D., Petrofsky, M., and Bermudez, L. E., “Identification of virulence determinants of Mycobacterium avium that impact on the ability to resist host killing mechanisms.”, J Med Microbiol, vol. 59, no. Pt 1, pp. 8-16, 2010.
L. Danelishvili, Yamazaki, Y., Selker, J., and Bermudez, L. E., “Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins participate in the suppression of macrophage apoptosis.”, PLoS One, vol. 5, no. 5, p. e10474, 2010.
2008
L. E. Bermudez, Motamedi, N., Kolonoski, P., Chee, C., Baimukanova, G., Bildfell, R. J., Wang, G., Phan, L. Tam, and S Lowell, Y., “The efficacy of clarithromycin and the bicyclolide EDP-420 against Mycobacterium avium in a mouse model of pulmonary infection.”, The Journal of infectious diseases, vol. 197, no. 11, pp. 1506-10, 2008.
2007
L. Danelishvili, Wu, M., Stang, B. V., Harriff, M., Cirillo, S. L. G., Cirillo, S., Cirillo, J. D., Cirillo, J., Bildfell, R. J., Arbogast, B., and Bermudez, L. E., “Identification of Mycobacterium avium pathogenicity island important for macrophage and amoeba infection.”, Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 11038-43, 2007.
L. Danelishvili, Wu, M., Stang, B., Harriff, M., Cirillo, S. L. G., Cirillo, S., Cirillo, J. D., Cirillo, J., Bildfell, R., Arbogast, B., and Bermudez, L. E., “Identification of Mycobacterium avium pathogenicity island important for macrophage and amoeba infection.”, Proc Natl Acad Sci U S A, vol. 104, no. 26, pp. 11038-43, 2007.
2006
L. Danelishvili, Young, L. S., and Bermudez, L. E., “In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.”, Microbial drug resistance (Larchmont, N.Y.), vol. 12, no. 1, pp. 1-6, 2006.
L. Danelishvili, Young, L. S., and Bermudez, L. E., “In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.”, Microb Drug Resist, vol. 12, no. 1, pp. 1-6, 2006.
2004
L. Danelishvili, Poort, M. J., and Bermudez, L. E., “Identification of Mycobacterium avium genes up-regulated in cultured macrophages and in mice.”, FEMS Microbiol Lett, vol. 239, no. 1, pp. 41-9, 2004.
2002
L. Broxmeyer, Sosnowska, D., Miltner, E., Chacon, O., Wagner, D., McGarvey, J., Barletta, R. G., and Bermudez, L. E., “Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.”, The Journal of infectious diseases, vol. 186, no. 8, pp. 1155-60, 2002.
D. Wagner, Sangari, F. J., Kim, S., Petrofsky, M., and Bermudez, L. E., “Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo.”, Journal of leukocyte biology, vol. 71, no. 1, pp. 80-8, 2002.
J. McGarvey and Bermudez, L. E., “Pathogenesis of nontuberculous mycobacteria infections.”, Clinics in chest medicine, vol. 23, no. 3, pp. 569-83, 2002.
2001
P. M. Roger and Bermudez, L. E., “Infection of mice with Mycobacterium avium primes CD8+ lymphocytes for apoptosis upon exposure to macrophages.”, Clinical immunology (Orlando, Fla.), vol. 99, no. 3, pp. 378-86, 2001.
J. A. McGarvey and Bermudez, L. E., “Phenotypic and genomic analyses of the Mycobacterium avium complex reveal differences in gastrointestinal invasion and genomic composition.”, Infection and immunity, vol. 69, no. 12, pp. 7242-9, 2001.
2000
H. S. Wu, Kolonoski, P., Chang, Y. Y., and Bermudez, L. E., “Invasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice.”, Infection and immunity, vol. 68, no. 5, pp. 2979-84, 2000.
1999
L. E. Bermudez and Petrofsky, M., “Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells.”, Infection and immunity, vol. 67, no. 6, pp. 3108-11, 1999.
L. E. Bermudez, Goodman, J., and Petrofsky, M., “Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice.”, Infection and immunity, vol. 67, no. 9, pp. 4912-6, 1999.
1998
L. E. Bermudez, Petrofsky, M., and Stevens, P., “Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.”, Immunology, vol. 94, no. 3, pp. 297-303, 1998.
1997
N. Azouaou, Petrofsky, M., Young, L. S., and Bermudez, L. E., “Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.”, Immunology, vol. 91, no. 3, pp. 414-20, 1997.
1996
L. E. Bermudez, Kolonoski, P., and Young, L. S., “Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.”, Antimicrobial agents and chemotherapy, vol. 40, no. 4, pp. 1033-5, 1996.
1995
E. M. Foley-Thomas, Whipple, D. L., Bermudez, L. E., and Barletta, R. G., “Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis.”, Microbiology (Reading, England), vol. 141 ( Pt 5), pp. 1173-81, 1995.
L. E. Bermudez and Kaplan, G., “Recombinant cytokines for controlling mycobacterial infections.”, Trends in microbiology, vol. 3, no. 1, pp. 22-7, 1995.
1994
L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B., “Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.”, Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.

Pages